The global Perfusion System Market size is
projected to reach USD 1.54 billion by 2030, according to a new report by Grand
View Research, Inc. Furthermore, the market is projected to advance at a CAGR
of 4.7% from 2022 to 2030. Factors such as the growing prevalence of chronic
diseases and the rise in the number of organ transplants and multiple organ
failures are anticipated to boost the market growth. In addition, increasing
investments in cell-based research and a rise in biologics manufacturing are
further expected to impel the growth of the perfusion system industry.
There was a steep downfall in the sales of perfusion
systems during the first half of the pandemic. The lockdowns and restrictions
imposed by governments globally resulted in reduced patient visits to
hospitals, a reduced number of surgeries, and a slowdown in R&D activities.
However, with the increasing efforts of the government and healthcare
professionals to curb the spread of the virus and prepare for similar events in
the future, the market began to recover in 2021 and is expected to flourish
during the forecast period.
Related Press Release@ Perfusion System Market Report
Perfusion System
Market Report Highlights
- Based on application, the perfusion systems market is segmented
into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo
organ perfusion system. The cardiopulmonary perfusion system dominated the
market in 2021 due to the high prevalence of cardiac diseases globally
- In terms of region, North America accounted for the highest market
share in 2021. The rising incidences of chronic disorders, a
well-established healthcare sector, and a rise in the number of organ
donors are driving the regional market growth
- The COVID-19 pandemic had a significant negative impact on the
market for perfusion systems. Factors such as the change in healthcare
priorities, social distancing, and global lockdowns resulted in a reduced
number of surgeries and a fall in the number of organ donations and
transplants
- The coronavirus outbreak led to a decline in the sales of perfusion
systems; however, post the first wave of the pandemic, the market
recovered and is expected to reach its pre-COVID growth level during the
forecast period
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment